G1 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02.12.2021 - RESEARCH TRIANGLE PARK, N.C., Dec. 01, 2021 (GLOBE NEWSWIRE) - G1 Therapeutics, Inc. (Nasdaq: GTHX), a commercial-stage oncology company, today announced the grant of inducement stock options exercisable for an aggregate of 101,700 shares of G1’s ...